Joseph Kuntze
Urology · Templeton, CANPI 1134210727
Payments from drug & device makers
Across 239 payments — averaging $25.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$1K
- AbbVie$697
- Dendreon Pharmaceuticals LLC$486
- Medtronic$464
- Johnson & Johnson$340
- Ferring Pharmaceuticals Inc.$266
- plus $3K from 29 others
What the payments were for
- Food & beverage$5,79295%
- Education$3115%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 41 | $1,152 |
| AbbVie(2 entities) | 29 | $697 |
| Dendreon Pharmaceuticals LLC | 20 | $486 |
| Medtronic(2 entities) | 7 | $464 |
| Johnson & Johnson | 19 | $340 |
| Ferring Pharmaceuticals Inc. | 9 | $266 |
| Urovant Sciences Inc | 16 | $236 |
| Tolmar Pharmaceuticals, Inc. | 11 | $234 |
| Pfizer | 6 | $201 |
| Bayer | 8 | $193 |
| Endo Pharmaceuticals Inc. | 10 | $191 |
| Myriad Genetic Laboratories, Inc. | 9 | $166 |
| Foundation Medicine, Inc. | 6 | $154 |
| Blue Earth Diagnostics | 7 | $152 |
| Antares Pharma, Inc. | 1 | $141 |
| Amgen | 5 | $129 |
| Clinical Laserthermia Systems Americas Inc. | 1 | $106 |
| Biotissue Holdings Inc. | 2 | $94 |
| Boston Scientific | 3 | $90 |
| Coloplast | 5 | $77 |
| Progenics Pharmaceuticals, Inc. | 3 | $74 |
| Philips North America LLC | 3 | $69 |
| AstraZeneca | 1 | $63 |
| Axonics, Inc. | 3 | $62 |
| Travere Therapeutics, Inc. | 2 | $35 |
| Therapeuticsmd, Inc. | 2 | $35 |
| Myovant Sciences Inc. | 2 | $34 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
| Metuchen Pharmaceuticals | 1 | $24 |
| Clovis Oncology, Inc. | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Merck | 1 | $20 |
| Baudax Bio Inc. | 1 | $19 |
| Laborie Medical Technologies Corp. | 1 | $14 |
| Verity Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,103 in reported general payments places this provider in the 65th percentile of 1,324 urology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $566 |
Paid to pharmacies, not to this prescriber.
Other urology in Templeton
- Edward UchioOrange$21.1M
- Stephen FreedlandWest Hollywood$16.7M
- Alec KooTorrance$7.4M
- Karim ChamieLos Angeles$4.3M
- Ralph ClaymanOrange$3.9M
- Siamak DaneshmandLos Angeles$3.5M
- Arnold ChinLos Angeles$3.5M
- Roger LiLoma Linda$2.3M
- John KowalczykLos Angeles$1.8M
- Arie BelldegrunLos Angeles$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.